Fine PE. Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev. 1982;4:161–88.
Suzuki K, Akama T, Kawashima A, Yoshihara A, Yotsu RR, Ishii N. Current status of leprosy: epidemiology, basic science and clinical perspectives. J Dermatol. 2012;39:121–9.
Rodrigues LC, Lockwood DNJ. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis. 2011;11:464–70.
Parkash O. Classification of leprosy into multibacillary and paucibacillary groups: An analysis. FEMS Immunol Med Microbiol. 2009;55:1–5.
Lockwood DNJ, Suneetha S. Leprosy: Too complex a disease for a simple elimination paradigm. Bull World Health Organ. 2005;83:230–5.
Shukla LK, Patel RN, Patel SV, Baxi RK. Evaluation of the effect of block level awareness campaign on performance indicators of National Leprosy Eradication Program in Vadodara district, Gujarat, India. Indian J Dermatology Venereol Leprol. 2015;81:257–62.
Araújo S, Lobato J, Reis ÉDM, Souza DOB, Gonçalves MA, Costa AV, et al. Unveiling healthy carriers and subclinical infections among household contacts of leprosy patients who play potential roles in the disease chain of transmission. Mem Inst Oswaldo Cruz. 2012;107:55–9.
Reich C. Leprosy: Cause, transmission, and a new theory of pathogenesis. Rev Infect Dis. 1987;9:590–4.
West BC, Todd JR, Lary CH, Blake LA, Fowler ME, King JW. Leprosy in six isolated residents of northern Louisiana. Time-clustered cases in an essentially nonendemic area. Arch Intern Med. 1988;148:1987–92.
Klatser PR, van Beers S, Madjid B, Day R, de Wit MY. Detection of Mycobacterium leprae in nasal carriers in populations for which leprosy is endemic. J Clin Microbiol. 1993;31:2947–51.
Beyene D, Aseffa A, Harboe M, Kidane D, Macdonald M, Klatser PR, et al. Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia. Epidemiol Infect. 2003;131:841–8.
Fine P. BCG vaccination against tuberculosis and leprosy. Br Med Bull. 1988;44:691–703.
Davey T, Rees R. The nasal discharge in leprosy: clinical and bacteriological aspects. Lepr Rev. 1974;45:121–34.
Job CK, Jayakumar J, Kearney M, Gillis TP. Transmission of leprosy: A study of skin and nasal secretions of household contacts of leprosy patients using PCR. Am J Trop Med Hyg. 2008;78:518–21.
McDougall A, Rees R, Weddell A, Kanan M. The histopathology of lepromatous leprosy in the nose. J Pathol. 1975;115:215–26.
Casanova J-L, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620.
Chaussinaud R. Tuberculose et Lepre, Maladies Antagoniques. Int J Lepr Other Mycobact. 1948;16:431–48.
Chaussinaud R. Tuberculosis and leprosy; mutually antagonistic diseases. Lepr Rev. 1953;24:90.
Lietman T, Porco T, Blower S. Leprosy and Tuberculosis: The epidemiological consequences of cross-immunity. Am J Public Health. 1997;87:1923–7.
Trunz BB, Trunz BB, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006;367:1173–80.
World Health Organization. Global leprosy update, 2014: need for early case detection. Wkly Epidemiol Rec. 2015;36:461–74.
Uniting to Combat NTDs. London declaration. [http://unitingtocombatntds.org/]. 5 Oct. 2015.
World Health Organization. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. 2012.
Alberts CJ, Smith WCS, Meima A, Wang L, Richardus JH. Potential effect of the World Health Organization’s 2011-2015 global leprosy strategy on the prevalence of grade 2 disability: a trend analysis. Bull World Health Organ. 2011;89:487–95.
World Health Organization. Enhanced global strategy for further reducing the disease burden due to leprosy (2011-2015). 2009. [http://www.searo.who.int/entity/global_leprosy_programme/documents/enhanced_global_strategy_2011_2015.pdf] Accessed 9 Oct 2015.
World Health Organization. Bangkok declaration: towards a leprosy-free World. In: International leprosy summit: overcoming the remaining challenges. Bangkok, Thailand: World Health Organization; 2013.
Robbins G, Tripathy VM, Misra VN, Mohanty RK, Shinde VS, Gray KM, et al. Ancient skeletal evidence for leprosy in India (2000 B.C.). PLoS One. 2009;4:1–8.
Global Administrative Areas. Global Administrative Areas. 2015. [http://gadm.org]. 3 August 2015.
Datameet. Datameet. 2015. [datameet.org]. 3 August 2015.
Programme NLE. District wise annual new case detection and prevalence as on March 2008. 2008.
Program NLE. District wise annual new case detection and prevalence as on March 2009. 2009.
Program NLE. District wise annual new case detection and prevalence as on March 2010. 2010.
Program NLE. District wise annual new case detection and prevalence as on March 2011. 2011.
Program NLE. District wise annual new case detection and prevalence as on March 2012. 2012.
Program NLE. District wise annual new case detection and prevalence as on March 2013. 2013.
Program NLE. District wise annual new case detection and prevalence as on March 2014. 2014.
Program NLE. District wise annual new case detection and prevalence as on March 2015. 2015.
Central Leprosy Division DG of HSN. Progress report for the year 2008-09 ending on 31st March 2009. 2009.
Central Leprosy Division DG of HSN. Progress report for the year 2009-10 ending on 31st March 2010. 2010.
Central Leprosy Division DG of HSN. Progress report for the year 2010-11 ending on 31st March 2011. 2011.
Central Leprosy Division DG of HSN. Progress report for the year 2011-12 ending on 31st March 2012. 2012.
Central Leprosy Division DG of HSN. Progress report for the year 2012-13 ending on 31st March 2013. 2013.
Central Leprosy Division DG of HSN. Progress report for the year 2013-14 ending on 31st March 2014. 2014.
Revised National Tuberculosis Control Programme (RNTCP) Annual Reports [http://www.tbcindia.nic.in/]. 29 August 2015.
Immunization Status of Children (12-23 months) [https://data.gov.in/catalog/immunization-status-children-12-23-months#web_catalog_tabs_block_10]. 29 August 2015.
Programme Implementation Plan (PIP) for 12th Plan Period. [http://nlep.nic.in/pdf/Final%20PIP,on%203%20May%202013.pdf]. 29 August 2015.
Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman and Hall; 1993.
West BT, Welch KB, Galecki AT. Linear mixed models. A practical guide using statistical sofware. 2nd ed. Boca Raton: Chapman and Hall/CRC; 2014.
Johnson PCD. Extension of Nakagawa & Schielzeth’s R2
to random slopes models. Methods Ecol Evol. 2014;5:944–6.
Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol Evol. 2013;4:133–42.
Smith WC, van Brakel W, Gillis T, Saunderson P, Richardus JH. The missing millions: a threat to the elimination of leprosy. PLoS Negl Trop Dis. 2015;9:e0003658.
World Health Organization. National programme managers for leprosy elimination. Report of an Intercountry Meeting. Kathmandu, Nepal: World Health Organization; 2005.
Rao PN, Pratap DVS. Leprosy program in India at the crossroads. Int J Lepr Other Mycobact Dis. 2005;73:211–5.
Kumar A, Husain S. The burden of new leprosy cases in India: a population-based survey in two states. ISRN Tropical Medicine. 2013;2013:329283.
Kumar A, Girdhar A, Chakma JK, Girdhar BK. Detection of previously undetected leprosy cases in Firozabad District (U.P.), India during 2006-2009: A short communication. Lepr Rev. 2013;84:124–7.
Shetty VP, Thakar UH, D’souza E, Ghate SD, Arora S, Doshi RP, et al. Detection of previously undetected leprosy cases in a defined rural and urban area of Maharashtra, Western India. Lepr Rev. 2009;80:22–33.
Solomon AW, Zondervan M, Kuper H, Buchan JC, Mabey DCW, Foster A. Trachoma control: A guide for programme managers. Geneva, Switzerland: World Health Organization; 2006.
Deepak S, Gazzoli G. Leprosy control. In: Nunzi E, Massone C, editors. Leprosy: a practical guide. Milan: Springer Verlag Italia; 2012. p. 361–70.
Harris TE. The theory of branching processes. Berlin: Springer-Verlag, 1963.
Bartoszynski R. Branching processes and the theory of epidemics. In: Proceedings of the Fifth Berkeley symposium. 1967. p. 259–69.
Blumberg S, Worden L, Enanoria W, Ackley S, Deiner M, Liu F, et al. Assessing measles transmission in the United States following a large outbreak in California. PLoS Curr. 2015.
Blok DJ, de Vlas SJ, Richardus JH. Global elimination of leprosy by 2020: are we on track? Parasites and Vectors. 2015. doi:10.1186/s13071-015-1143-4
Crump RE, Medley GF. Back-calculating the incidence of infection of leprosy in a Bayesian framework. Parasites and Vectors. 2015. doi:10.1186/s13071-015-1142-5
Pandey A. Current perspectives on leprosy as a public health challenge in India. Res Rep Trop Med. 2015;2015:643–8.
Richardus JH, Oskam L. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis. Clin Dermatol. 2015;33:19–25.